- Home
- GSBC vs VIR Comparison
GSBC vs VIR Comparison
Compare GSBC & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- VIR
- Stock Information
- Founded
- GSBC 1923
- VIR 2016
- Country
- GSBC United States
- VIR United States
- Employees
- GSBC N/A
- VIR N/A
- Industry
- GSBC Major Banks
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- VIR Health Care
- Exchange
- GSBC Nasdaq
- VIR Nasdaq
- Market Cap
- GSBC 676.3M
- VIR 706.4M
- IPO Year
- GSBC N/A
- VIR 2019
- Fundamental
- Price
- GSBC $62.41
- VIR $4.38
- Analyst Decision
- GSBC Hold
- VIR Strong Buy
- Analyst Count
- GSBC 2
- VIR 8
- Target Price
- GSBC $60.50
- VIR $30.25
- AVG Volume (30 Days)
- GSBC 39.8K
- VIR 1.1M
- Earning Date
- GSBC 10-15-2025
- VIR 08-06-2025
- Dividend Yield
- GSBC 2.55%
- VIR N/A
- EPS Growth
- GSBC 17.24
- VIR N/A
- EPS
- GSBC 5.86
- VIR N/A
- Revenue
- GSBC $224,299,000.00
- VIR $19,000,000.00
- Revenue This Year
- GSBC N/A
- VIR N/A
- Revenue Next Year
- GSBC N/A
- VIR $0.56
- P/E Ratio
- GSBC $10.70
- VIR N/A
- Revenue Growth
- GSBC 4.82
- VIR N/A
- 52 Week Low
- GSBC $47.58
- VIR $4.16
- 52 Week High
- GSBC $68.02
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- GSBC 64.77
- VIR 38.03
- Support Level
- GSBC $59.37
- VIR $4.25
- Resistance Level
- GSBC $63.00
- VIR $4.66
- Average True Range (ATR)
- GSBC 1.31
- VIR 0.23
- MACD
- GSBC 0.49
- VIR 0.00
- Stochastic Oscillator
- GSBC 92.29
- VIR 24.06
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.